SeaStar Medical shareholders approve board, equity plan amendment, Lincoln Park issuance

SeaStar Medical Holding Corp

Elected Eric Schlorff (2,369,794 for) and Kenneth Van Heel (2,674,923 for) as Class III directors.
Approved amendment to 2022 Omnibus Equity Incentive Plan: shares increased from ~570K to 2,070,457; evergreen provision removed.
Approved potential future sale of common stock to Lincoln Park that could exceed 19.99% of outstanding shares (2,596,164 for).
Ratified WithumSmith+Brown as independent auditor for FY2025 (6,168,023 for).
Adjournment proposal approved (5,240,780 for) to allow further proxy solicitation if needed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.